Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia (Q24599100)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q87934467)
(Q89672650)
(Q89030667)
(P304) 2578-85
(P407) (Q1860)
(P433) 13
(P478) 115
(P577) Thursday, April 1, 2010
(P921) (Q7141)
(Q715347)
(Q29496)
(Q1138590)
(Q1088156)
(P1433) (Q885070)
(P1476) "Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia" (language: en)
(P2093) Jonathan W Friedberg
Jeff Sharman
John Sweetenham
Patrick B Johnston
Julia Schaefer-Cutillo
Sven De Vos
Rajni Sinha
John P Leonard
Larry D Cripe
Stephanie A Gregory
Michael P Sterba
Ann M Lowe
Ronald Levy
(P2860) (Q28145413)
(Q28274089)
(Q28248195)
(Q28613911)
(Q33385283)
(Q37028635)
(Q37234623)
(Q33382517)
(Q37328562)
(Q34162571)
(Q36445884)
(Q40218154)
(Q33372761)
(Q34562439)
(Q40243215)
(Q34554188)
(Q40284461)
(Q36430140)
(Q40330626)
(Q35807570)
(Q34662623)
(Q40867426)
(Q33773306)
(Q33632426)
(Q42184742)
(Q42742097)
(Q47960638)
(Q46183731)
(Q46271720)
(Q46458338)
(Q53476669)
(Q51753817)
(Q47582438)
(Q57374967)
(Q47372605)
(Q55036524)
(Q44123850)
(Q52192552)
(Q79776234)
(Q83468851)
(Q81520263)
(Q83754475)